The academic–industrial complex: navigating the translational and cultural divide

In this review article, Stephen Freedman and Kevin Mullane offer a personal perspective on the opportunities, models and approaches that harness the increased interface and growing interdependency between biomedical research institutes, the biopharmaceutical industry and the technological world: In general, academic discoveries can only be translated into therapeutics through joint efforts with industry. However, the poor reproducibility of much academic research has damaged credibility and jeopardized translational efforts that could benefit patients. Meanwhile, journals are rife with articles bemoaning the limited productivity and increasing costs of the biopharmaceutical industry and its resultant predilection for mergers and reorganizations while decreasing internal research efforts. The ensuing disarray and uncertainty has created tremendous opportunities for academia and industry to form even closer ties, and to embrace new operational and financial models to their joint benefit. LINK

Share this

One Reply to “The academic–industrial complex: navigating the translational and cultural divide”

  1. Such a great piece. Excellent, really. There are usually so many people
    online claiming they will know the topic. In reality,
    it’s just you plus who truly
    know very well what they create about. I enjoy genuine content in addition to I feel like a lot of your readers do,

Leave a Reply

Your email address will not be published. Required fields are marked *